Equity Profile

SHC

Sotera Health Company

Health CareLife Sciences Tools & Services$5.4B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Sotera Health Company operates in the health care sector, focusing on life sciences tools and services. The company plays a crucial role in providing essential services for medical device and pharmaceutical companies, which is increasingly important as the demand for health care solutions continues to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$0.20

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in the health care industry.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SHC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+55.19%

Avg Stock Reaction

+2.38%

Last Quarter Recap

In Q1-2026, Sotera Health reported an EPS of $0.18, exceeding expectations by 17.65%. However, the stock experienced a slight decline of 0.39% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Sotera Health's upcoming earnings are mixed, given the company's strong EPS surprises in previous quarters but lack of revenue guidance.

Bull Case

If Sotera continues its trend of beating EPS estimates, it could signal strong operational efficiency and market demand, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet even its previous EPS performance, it may raise concerns about its growth prospects and lead to a negative market reaction.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.20

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its business and capture market share in the health care industry.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be critical in determining market sentiment and stock performance.

How is revenue growth trending in the current quarter?

Investors will be keen to understand revenue trends as they directly impact the company's overall growth narrative and future guidance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Sotera to exceed EPS expectations based on its historical performance.

Supporting Evidence

The company has a 100% EPS beat rate over the last eight quarters, indicating strong operational performance.

Options pricing suggests a larger move than historical averages, which may reflect heightened investor sentiment.

Recent trends in the life sciences sector indicate increased demand for Sotera's services, which may not be fully factored into current estimates.

Key Risk

If the EPS comes in below $0.18, it could undermine the positive growth narrative and shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the company's ability to maintain its EPS growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $0.20 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $0.18 would signal potential weakness and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±17.26%

Historical Avg

±6.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±17.3% while SHC has averaged ±6.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

24.5%

Calls (400)P/C Ratio: 0.50Puts (200)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Sotera beats expectations, history suggests the stock could rise by around 2.38%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors assess management's commentary.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop based on past reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth trends compared to previous quarters.
2Management's commentary on market demand for life sciences services.
3Insights into operational efficiencies that may impact future profitability.
4Details on any new contracts or partnerships that could drive future growth.
5Guidance on expectations for the remainder of the fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$0.20

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share in the health care industry.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

SHC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+55.19%

Avg Stock Reaction

+2.38%

Last Quarter Recap

In Q1-2026, Sotera Health reported an EPS of $0.18, exceeding expectations by 17.65%. However, the stock experienced a slight decline of 0.39% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Sotera Health's upcoming earnings are mixed, given the company's strong EPS surprises in previous quarters but lack of revenue guidance.

Bull Case

If Sotera continues its trend of beating EPS estimates, it could signal strong operational efficiency and market demand, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet even its previous EPS performance, it may raise concerns about its growth prospects and lead to a negative market reaction.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.20

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its business and capture market share in the health care industry.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be critical in determining market sentiment and stock performance.

How is revenue growth trending in the current quarter?

Investors will be keen to understand revenue trends as they directly impact the company's overall growth narrative and future guidance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Sotera to exceed EPS expectations based on its historical performance.

Supporting Evidence

The company has a 100% EPS beat rate over the last eight quarters, indicating strong operational performance.

Options pricing suggests a larger move than historical averages, which may reflect heightened investor sentiment.

Recent trends in the life sciences sector indicate increased demand for Sotera's services, which may not be fully factored into current estimates.

Key Risk

If the EPS comes in below $0.18, it could undermine the positive growth narrative and shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the company's ability to maintain its EPS growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $0.20 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $0.18 would signal potential weakness and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±17.26%

Historical Avg

±6.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±17.3% while SHC has averaged ±6.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

24.5%

Calls (400)P/C Ratio: 0.50Puts (200)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Sotera beats expectations, history suggests the stock could rise by around 2.38%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors assess management's commentary.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop based on past reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth trends compared to previous quarters.
2Management's commentary on market demand for life sciences services.
3Insights into operational efficiencies that may impact future profitability.
4Details on any new contracts or partnerships that could drive future growth.
5Guidance on expectations for the remainder of the fiscal year.